Evidence map›Paper›PMID 37457939›Full record

ArticleInternational journal of bioprinting2023

Swelling compensation of engineered vasculature fabricated by additive manufacturing and sacrifice-based technique using thermoresponsive hydrogel.

Xue Yang, Shuai Li, Xin Sun, Ya Ren, Lei Qiang, Yihao Liu, Jinwu Wang, Kerong Dai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of bioprinting, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Biofabrication of engineered blood vessels for biomedical applications.Science and technology of advanced materials · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xue YangCollege of Medicine, Southwest Jiaotong University, No. 144 Jiaoda Road, Chengdu 610031, People's Republic of China.
Shuai LiDepartment of Orthopedics, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Rd, Hangzhou 310003, People's Republic of China.
Xin SunShanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Rd, Shanghai 200011, People's Republic of China.
Ya RenCollege of Medicine, Southwest Jiaotong University, No. 144 Jiaoda Road, Chengdu 610031, People's Republic of China.
Lei QiangSchool of Materials Science and Engineering, Southwest Jiaotong University, No. 111 2nd Ring Rd, Chengdu 611756, People's Republic of China.
Yihao LiuShanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Rd, Shanghai 200011, People's Republic of China.
Jinwu WangShanghai Key Laboratory of Orthopedic Implants, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhizaoju Rd, Shanghai 200011, People's Republic of China.
Kerong DaiCollege of Medicine, Southwest Jiaotong University, No. 144 Jiaoda Road, Chengdu 610031, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Engineered vasculature is widely employed to maintain the cell viability within

Indexed as

Additive manufacturingEngineered vasculaturesSacrificial materialsSwelling compensationThermoresponsive hydrogels

Identifiers

PMID37457939
PMCPMC10339422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.